BIONET Statistics

Total Valuation

BIONET has a market cap or net worth of TWD 3.49 billion. The enterprise value is 3.07 billion.

Market Cap	3.49B
Enterprise Value	3.07B

Important Dates

The last earnings date was Friday, March 28, 2025.

Earnings Date	Mar 28, 2025
Ex-Dividend Date	Sep 19, 2024

Share Statistics

BIONET has 50.83 million shares outstanding. The number of shares has increased by 0.33% in one year.

Current Share Class	n/a
Shares Outstanding	50.83M
Shares Change (YoY)	+0.33%
Shares Change (QoQ)	+0.52%
Owned by Insiders (%)	9.39%
Owned by Institutions (%)	0.27%
Float	40.37M

Valuation Ratios

The trailing PE ratio is 41.64.

PE Ratio	41.64
Forward PE	n/a
PS Ratio	2.86
PB Ratio	1.46
P/TBV Ratio	2.67
P/FCF Ratio	46.47
P/OCF Ratio	19.78
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 30.50, with an EV/FCF ratio of 40.89.

EV / Earnings	36.71
EV / Sales	2.51
EV / EBITDA	30.50
EV / EBIT	49.25
EV / FCF	40.89

Financial Position

The company has a current ratio of 5.06, with a Debt / Equity ratio of 0.04.

Current Ratio	5.06
Quick Ratio	4.77
Debt / Equity	0.04
Debt / EBITDA	0.94
Debt / FCF	1.25
Interest Coverage	48.78

Financial Efficiency

Return on equity (ROE) is 3.39% and return on invested capital (ROIC) is 1.83%.

Return on Equity (ROE)	3.39%
Return on Assets (ROA)	1.42%
Return on Invested Capital (ROIC)	1.83%
Return on Capital Employed (ROCE)	2.26%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.44
Inventory Turnover	7.84

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +15.12% in the last 52 weeks. The beta is 0.59, so BIONET's price volatility has been lower than the market average.

Beta (5Y)	0.59
52-Week Price Change	+15.12%
50-Day Moving Average	79.65
200-Day Moving Average	94.01
Relative Strength Index (RSI)	38.74
Average Volume (20 Days)	328,938

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BIONET had revenue of TWD 1.22 billion and earned 83.70 million in profits. Earnings per share was 1.65.

Revenue	1.22B
Gross Profit	685.77M
Operating Income	62.40M
Pretax Income	102.24M
Net Income	83.70M
EBITDA	89.71M
EBIT	62.40M
Earnings Per Share (EPS)	1.65

Full Income Statement

Balance Sheet

The company has 1.57 billion in cash and 94.28 million in debt, giving a net cash position of 1.48 billion or 29.12 per share.

Cash & Cash Equivalents	1.57B
Total Debt	94.28M
Net Cash	1.48B
Net Cash Per Share	29.12
Equity (Book Value)	2.40B
Book Value Per Share	26.26
Working Capital	1.60B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 176.49 million and capital expenditures -101.35 million, giving a free cash flow of 75.15 million.

Operating Cash Flow	176.49M
Capital Expenditures	-101.35M
Free Cash Flow	75.15M
FCF Per Share	1.48

Full Cash Flow Statement

Margins

Gross margin is 56.12%, with operating and profit margins of 5.11% and 6.85%.

Gross Margin	56.12%
Operating Margin	5.11%
Pretax Margin	8.37%
Profit Margin	6.85%
EBITDA Margin	7.34%
EBIT Margin	5.11%
FCF Margin	6.15%

Dividends & Yields

This stock pays an annual dividend of 1.41, which amounts to a dividend yield of 2.11%.

Dividend Per Share	1.41
Dividend Yield	2.11%
Dividend Growth (YoY)	9.05%
Years of Dividend Growth	4
Payout Ratio	39.61%
Buyback Yield	-0.33%
Shareholder Yield	1.78%
Earnings Yield	2.40%
FCF Yield	2.15%

Dividend Details

Stock Splits

The last stock split was on September 19, 2024. It was a forward split with a ratio of 1.070923771.

Last Split Date	Sep 19, 2024
Split Type	Forward
Split Ratio	1.070923771

Scores

BIONET has an Altman Z-Score of 4.44.

Altman Z-Score	4.44
Piotroski F-Score	n/a